• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

hyon.tan@unimelb.edu.au

Credentials


Position
Research Officer
Department of Microbiology and Immunology
Education
PhD
University of Melbourne
Bachelors Degree (Honours)
University of Otago
ORCID

0000-0003-1064-3934

Dr Hyon Xhi Tan

Research Officer
Department of Microbiology and Immunology

68 Scholarly works
6 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Evaluating southern pigtail macaques as an immunological model for human antibody responses
    DOI: 10.1038/s41598-026-42695-6
  • 2026

    Journal article

    Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza
    DOI: 10.1016/j.omtn.2026.102873
  • 2026

    Journal article

    Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity.
    DOI: 10.1038/s41467-026-73988-z
  • 2026

    Journal article

    Immune responses associated with protection from SARS-CoV-2 infection
    DOI: 10.1016/j.vaccine.2026.128579
  • 2023

    Research grants (other domestic)

    Monoclonal Antibodies to Treat and Prevent Orthopoxvirus and Henipavirus Pandemic Threats
  • 2022

    Research grants (ARC, NHMRC, MRFF)

    Driving Rational Improvement of Vaccines Against Respiratory Viruses
  • 2021

    Research grants (ARC, NHMRC, MRFF)

    Chimeric Next Generation COVID Vaccines
Hyon Xhi Tan

Latest Honours,
Awards and Fellowships


2022
Frank Fenner Investigator Grant Award NHMRC

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality
    DOI: 10.1016/j.ebiom.2026.106185
  • 2026

    Journal article

    Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses
    DOI: 10.1126/scitranslmed.aea8621
  • 2025

    Journal article

    Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
    DOI: 10.1038/s44298-025-00116-x
  • 2025

    Journal article

    Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies
    DOI: 10.1038/s41467-025-62339-z
  • 2025

    Journal article

    T follicular helper cell differentiation programs immunogenicity of prototypic influenza vaccines 4602
    DOI: 10.1093/jimmun/vkaf283.2264
  • 2025

    Journal article

    Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines
    DOI: 10.1016/j.omtn.2025.102547

RECENT PROJECTS

  • 2021

    Research grants (ARC, NHMRC, MRFF)

    Harnessing T Cell Quality for Pandemic Preparedness
  • 2021

    Research grants (ARC, NHMRC, MRFF)

    Chimeric Next Generation COVID Vaccines

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224